1211 related articles for article (PubMed ID: 15916014)
1. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
Marogna M; Spadolini I; Massolo A
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
[TBL] [Abstract][Full Text] [Related]
2. The allergic march in pollinosis: natural history and therapeutic implications.
Marogna M; Falagiani P; Bruno M; Massolo A; Riva G
Int Arch Allergy Immunol; 2004 Dec; 135(4):336-42. PubMed ID: 15564776
[TBL] [Abstract][Full Text] [Related]
3. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.
Magnan A; Meunier JP; Saugnac C; Gasteau J; Neukirch F
Allergy; 2008 Mar; 63(3):292-8. PubMed ID: 18028246
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of patients with allergic polysensitization: the POLISMAIL study.
Ciprandi G; Alesina R; Ariano R; Aurnia P; Borrelli P; Cadario G; Capristo A; Carosso A; Casino G; Castiglioni G; Cesinaro Di Rocco P; Colangelolo C; Di Gioacchino M; Di Paola MG; Errico G; Fiorina A; Gambuzza F; Gangemi S; Gasparini A; Giugno R; Iemoli E; Isola S; Maniero G; Marengo F; Mazzali P; Minelli M; Mosca M; Pellegrino R; Piconi S; Pravettoni V; Quaglio L; Ricciardi L; Ridolo E; Sillano V; Valle C; Varin E; Verini M; Zambito M; Riario-Sforza GG; Incorvaia C; Puccinelli P; Scurati S; Frati F
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):77-83. PubMed ID: 19334371
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy for allergic respiratory disease in elderly patients: a retrospective study.
Marogna M; Bruno ME; Massolo A; Falagiani P
Eur Ann Allergy Clin Immunol; 2008 May; 40(1):22-9. PubMed ID: 18700331
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
[TBL] [Abstract][Full Text] [Related]
8. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
[TBL] [Abstract][Full Text] [Related]
10. A case control study of dermatophagoides immunotherapy in children below 5 years of age.
Di Bernardino C; Di Bernardino F; Colombo R; Angrisano A
Allerg Immunol (Paris); 2002 Feb; 34(2):56-9. PubMed ID: 11933755
[TBL] [Abstract][Full Text] [Related]
11. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma.
Antonicelli L; Micucci C; Voltolini S; Senna GE; Di Blasi P; Visonà G; De Marco R; Bonifazi F
Allergy; 2007 Sep; 62(9):1064-70. PubMed ID: 17686109
[TBL] [Abstract][Full Text] [Related]
12. Sublingual immunotherapy in the context of a clinical practice improvement program in the allergological setting: results of a long-term observational study.
Marogna M; Massolo A
Eur Ann Allergy Clin Immunol; 2003 Apr; 35(4):133-40. PubMed ID: 12793117
[TBL] [Abstract][Full Text] [Related]
13. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: A long-term (13-year) retrospective study in real life.
Marogna M; Bruno M; Massolo A; Falagiani P
Int Arch Allergy Immunol; 2007; 142(1):70-8. PubMed ID: 17016060
[TBL] [Abstract][Full Text] [Related]
15. Intercellular adhesion molecule 1 and tumor necrosis factor alpha in asthma and persistent allergic rhinitis: relationship with disease severity.
Gorska-Ciebiada M; Ciebiada M; Gorska MM; Gorski P; Grzelewska-Rzymowska I
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):66-72. PubMed ID: 16892784
[TBL] [Abstract][Full Text] [Related]
16. Impact of allergic rhinitis on asthma: effects on spirometric parameters.
Ciprandi G; Cirillo I; Pistorio A
Allergy; 2008 Mar; 63(3):255-60. PubMed ID: 17944984
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
[TBL] [Abstract][Full Text] [Related]
20. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
